Inception Return
(6/26/2008)
|
4.42 %
|
|
YTD Return
|
-7.66 %
|
|
NAVPS
(9/25/2020)
|
$12.28
|
|
Change
|
$0.04 / 0.31 %
|
|
|
Growth of $10,000
(As of August 31, 2020)
|
|
MER
|
2.33 %
|
|
Assets ($mil)
|
$98.61
|
|
Rank (1Yr)
|
358/387
|
|
Std Dev (3Yr)
|
7.91 %
|
|
Volatility Ranking (3Yr)
|
3/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or Back
|
|
Max Front End
|
6.00 %
|
|
Max Back End
|
6.00 %
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund’s investment objective is to provide current income while maintaining prospects for capital appreciation by investing primarily in debt and equity securities issued around the world.
|
Management Co.
Franklin Templeton Investments Corp.
Managers
Michael Hasenstab, Herbert Arnett, Franklin Advisers, Inc., Templeton Global Advisors Limited
|
|
Asset Allocation
(As of June 30, 2020)
|
Sector Allocation
(As of June 30, 2020)
|
Geographic Allocation
(As of June 30, 2020)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Federal Home Loan Banks 0.00% 01-Jul-2020 | Cash and Equivalents | Cash and Cash Equivalent | United States | 8.99% |
| Japan Government 0.10% 01-Feb-2021 | Cash and Equivalents | Cash and Cash Equivalent | Japan | 4.82% |
| Norway Government 3.75% 25-May-2021 | Foreign Bonds | Fixed Income | Other European | 3.20% |
| Bank of Korea 1.18% 02-Aug-2021 | Foreign Bonds | Fixed Income | Other Asian | 2.25% |
| Samsung Electronics Co Ltd | International Equity | Technology | Other Asian | 2.23% |
| Bayer AG | International Equity | Healthcare | European Union | 2.05% |
| Comcast Corp Cl A | US Equity | Telecommunications | United States | 1.87% |
| Takeda Pharmaceutical Co Ltd | International Equity | Healthcare | Japan | 1.75% |
| E.ON SE | International Equity | Utilities | European Union | 1.70% |
| Japan Treasury Discount Bill 0.00% 11-Aug-2020 | Cash and Equivalents | Cash and Cash Equivalent | Japan | 1.56% |
Performance Data
(As of August 31, 2020)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
0.31
|
0.78
|
-2.37
|
-7.66
|
-3.28
|
-2.52
|
-0.49
|
4.59
|
|
Benchmark
|
0.41
|
3.79
|
7.00
|
5.71
|
9.58
|
8.35
|
7.42
|
9.15
|
|
Quartile Ranking
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
Calendar Return (%)
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
|
Fund
|
0.66
|
-3.42
|
5.09
|
0.93
|
12.09
|
5.18
|
20.28
|
12.53
|
-3.61
|
7.16
|
|
Benchmark
|
12.26
|
2.68
|
8.66
|
2.39
|
17.05
|
12.44
|
18.86
|
8.49
|
0.80
|
4.85
|
|
Quartile Ranking
|
4
|
3
|
3
|
4
|
1
|
4
|
1
|
1
|
4
|
4
|
MSCI ESG Fund Metrics (As of September 01, 2020)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.